Literature DB >> 20551407

Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer.

Samuel Cykert1, Peggye Dilworth-Anderson, Michael H Monroe, Paul Walker, Franklin R McGuire, Giselle Corbie-Smith, Lloyd J Edwards, Audrina Jones Bunton.   

Abstract

CONTEXT: Lung cancer is the leading cause of cancer death in the United States. Surgical resection for stage I or II non-small cell cancer remains the only reliable treatment for cure. Patients who do not undergo surgery have a median survival of less than 1 year. Despite the survival disadvantage, many patients with early-stage disease do not receive surgical care and rates are even lower for black patients.
OBJECTIVES: To identify potentially modifiable factors regarding surgery in patients newly diagnosed with early-stage lung cancer and to explore why blacks undergo surgery less often than whites. DESIGN, SETTING, AND PATIENTS: Prospective cohort study with patients identified by pulmonary, oncology, thoracic surgery, and generalist practices in 5 communities through study referral or computerized tomography review protocol. A total of 437 patients with biopsy-proven or probable early-stage lung cancer were enrolled between December 2005 and December 2008. Before establishment of treatment plans, patients were administered a survey including questions about trust, patient-physician communication, attitudes toward cancer, and functional status. Information about comorbid illnesses was obtained through chart audits. MAIN OUTCOME MEASURE: Lung cancer surgery within 4 months of diagnosis.
RESULTS: A total of 386 patients met full eligibility criteria for lung resection surgery. The median age was 66 years (range, 26-90 years) and 29% of patients were black. The surgical rate was 66% for white patients (n = 179/273) compared with 55% for black patients (n = 62/113; P = .05). Negative perceptions of patient-physician communication manifested by a 5-point decrement on a 25-point communication scale (odds ratio [OR], 0.42; 95% confidence interval [CI], 0.32-0.74) and negative perception of 1-year prognosis postsurgery (OR, 0.27; 95% CI, 0.14-0.50; absolute risk, 34%) were associated with decisions against surgery. Surgical rates for blacks were particularly low when they had 2 or more comorbid illnesses (13% vs 62% for <2 comorbidities; OR, 0.04 [95% CI, 0.01-0.25]; absolute risk, 49%) and when blacks lacked a regular source of care (42% with no regular care vs 57% with regular care; OR, 0.20 [95% CI, 0.10-0.43]; absolute risk, 15%).
CONCLUSIONS: A decision not to undergo surgery by patients with newly diagnosed lung cancer was independently associated with perceptions of communication and prognosis, older age, multiple comorbidities, and black race. Interventions to optimize surgery should consider these factors.

Entities:  

Mesh:

Year:  2010        PMID: 20551407      PMCID: PMC4152904          DOI: 10.1001/jama.2010.793

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  37 in total

1.  Recent developments in the treatment of lung cancer.

Authors:  A Y Lin; D C Ihde
Journal:  JAMA       Date:  1992-03-25       Impact factor: 56.272

2.  Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer.

Authors:  Richard J Battafarano; Jay F Piccirillo; Bryan F Meyers; Han-Shui Hsu; Tracey J Guthrie; Joel D Cooper; G Alexander Patterson
Journal:  J Thorac Cardiovasc Surg       Date:  2002-02       Impact factor: 5.209

3.  The Mental Adjustment to Cancer (MAC) scale: replication and refinement in 632 breast cancer patients.

Authors:  R H Osborne; G R Elsworth; D W Kissane; S A Burke; J L Hopper
Journal:  Psychol Med       Date:  1999-11       Impact factor: 7.723

4.  Bayesian statistical theory in the preoperative diagnosis of pulmonary lesions.

Authors:  F H Edwards; P S Schaefer; S Callahan; G M Graeber; R A Albus
Journal:  Chest       Date:  1987-11       Impact factor: 9.410

5.  Patient race/ethnicity and quality of patient-physician communication during medical visits.

Authors:  Rachel L Johnson; Debra Roter; Neil R Powe; Lisa A Cooper
Journal:  Am J Public Health       Date:  2004-12       Impact factor: 9.308

6.  A matter of trust--patient's views on decision-making in colorectal cancer.

Authors:  Glenn Salkeld; Michael Solomon; Leonie Short; Phyllis N Butow
Journal:  Health Expect       Date:  2004-06       Impact factor: 3.377

7.  African American patients' perspectives on medical decision making.

Authors:  Alexia M Torke; Giselle M Corbie-Smith; William T Branch
Journal:  Arch Intern Med       Date:  2004-03-08

8.  Surgical decisions for early stage, non-small cell lung cancer: which racially sensitive perceptions of cancer are likely to explain racial variation in surgery?

Authors:  Samuel Cykert; Nancy Phifer
Journal:  Med Decis Making       Date:  2003 Mar-Apr       Impact factor: 2.583

9.  Survival analysis of untreated patients with non-small-cell lung cancer.

Authors:  E Vrdoljak; K Mise; D Sapunar; A Rozga; M Marusić
Journal:  Chest       Date:  1994-12       Impact factor: 9.410

10.  Racial disparities among patients with lung cancer who were recommended operative therapy.

Authors:  Farhood Farjah; Douglas E Wood; N David Yanez; Thomas L Vaughan; Rebecca Gaston Symons; Bahirathan Krishnadasan; David R Flum
Journal:  Arch Surg       Date:  2009-01
View more
  83 in total

1.  Stereotactic ablative radiotherapy (SABR) for lung cancer: What does the future hold?

Authors:  Billy W Loo
Journal:  J Thorac Dis       Date:  2011-09       Impact factor: 2.895

2.  Implementing effective and sustainable multidisciplinary clinical thoracic oncology programs.

Authors:  Raymond U Osarogiagbon; Richard K Freeman; Mark J Krasna
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 3.  What is quality, and can we define it in lung cancer?-the case for quality improvement.

Authors:  Farhood Farjah; Frank C Detterbeck
Journal:  Transl Lung Cancer Res       Date:  2015-08

4.  A taxonomy for contextual information in electronic health records.

Authors:  Charlene R Weir; Nancy Staggers; Kristina Doing-Harris; Robert Dunlea; Teresa McCormick; Robyn Barrus
Journal:  NI 2012 (2012)       Date:  2012-06-23

5.  Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.

Authors:  Alexander V Louie; George B Rodrigues; David A Palma; Suresh Senan
Journal:  Oncologist       Date:  2014-06-20

6.  Safety and tolerance of radical hysterectomy for cervical cancer in the elderly.

Authors:  Erin M George; Ana I Tergas; Cande V Ananth; William M Burke; Sharyn N Lewin; Eri Prendergast; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2014-04-24       Impact factor: 5.482

7.  Role of selected genetic variants in lung cancer risk in African Americans.

Authors:  Margaret R Spitz; Christopher I Amos; Susan Land; Xifeng Wu; Qiong Dong; Angela S Wenzlaff; Ann G Schwartz
Journal:  J Thorac Oncol       Date:  2013-04       Impact factor: 15.609

8.  Does Race Influence Risk Assessment and Recommendations for Lung Resection? A Randomized Trial.

Authors:  Mark K Ferguson; Carley Demchuk; Kristen Wroblewski; Megan Huisingh-Scheetz; Katherine Thompson; Jeanne Farnan; Julissa Acevedo
Journal:  Ann Thorac Surg       Date:  2018-06-11       Impact factor: 4.330

9.  Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.

Authors:  Christopher T Erb; Kevin W Su; Pamela R Soulos; Lynn T Tanoue; Cary P Gross
Journal:  Lung Cancer       Date:  2016-07-19       Impact factor: 5.705

10.  Patient Preferences in Treatment Choices for Early-Stage Lung Cancer.

Authors:  Betty C Tong; Scott Wallace; Matthew G Hartwig; Thomas A D'Amico; Joel C Huber
Journal:  Ann Thorac Surg       Date:  2016-09-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.